American Association for Cancer Research

SHERPA: Unknown

People

  1. Houghton
    Houghton
  2. Budhu
    Budhu
  3. Liu
    Liu
  4. Panageas
    Panageas
  5. Postow
    Postow
  6. Hirschhorn Cymerman
    Hirschhorn Cymerman
  7. Wong
    Wong
  8. Zhong
    Zhong
  9. Norton
    Norton
  10. Perales
    Perales

Groups

  1. Department of Medicine (94)
  2. GSK Faculty (94)
  3. Melanoma and Immunotherapeutics Service (94)
  4. Solid Tumor Oncology Division (94)
  5. Sloan Kettering Institute Postdocs (33)
  6. Sloan Kettering Institute Faculty (29)
  7. Hematologic Malignancies, Division of (25)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (24)
  9. Immunology Program Faculty (21)
  10. Epidemiology and Biostatistics (19)
Search Within
  1. "Jedd Wolchok"
Formats
  1. Meeting Abstract (57)
  2. Journal Article (35)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Department of Medicine (94)
  2. GSK Faculty (94)
  3. Melanoma and Immunotherapeutics Service (94)
  4. Solid Tumor Oncology Division (94)
  5. Sloan Kettering Institute Postdocs (33)
  6. Sloan Kettering Institute Faculty (29)

More Groups

People
  1. Jedd Wolchok (94)
  2. Taha Merghoub (39)
  3. Alan Houghton (21)
  4. Sadna Budhu (16)
  5. Paul Chapman (14)
  6. Cailian Liu (11)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (10)
  4. 2021 (3)
  5. 2020 (9)
  6. 2019 (10)

More Years

Publications
  1. Cancer Research (59)
  2. Clinical Cancer Research (35)

Results (94)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A successful prime-boost immunization strategy in a tumor model: Targeting tyrosinase in melanoma
    Meeting Abstract

    Goldberg, S. M.; Guevara-Patiño, J. A.; Gardner, J. P.; Montgomery, S. C.; Perales, M. A.; Donovan, G. P.; Olson, W. C.; Wolchok, J. D.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21
    Journal Article

    Ragupathi, G.; Livingston, P. O.; Hood, C.; Gathuru, J.; Krown, S. E.; Chapman, P. B.; Wolchok, J. D.; Williams, L. J.; Oldfield, R.; Hwu, W. J.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: A phase I trial
    Journal Article

    Bergman, P. J.; McKnight, J.; Novosad, A.; Charney, S.; Farrelly, J.; Craft, D.; Wulderk, M.; Jeffers, Y.; Sadelain, M.; Hohenhaus, A. E.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Phase I trial of human tyrosinase DNA vaccination in dogs with advanced malignant melanoma
    Meeting Abstract

    Bergman, P. J.; McKnight, J.; Novosad, A.; Chamey, S.; Farrelly, J.; Jeffers, Y.; Egan, M.; Craft, D.; Gallardo, H.; Riviere, I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: